Schedule 13G ownership disclosure
Cerulean Pharma Inc.
Security class unavailable · CUSIP: 15708Q105
Event date: 2014-04-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-14-149216
- Form type
- SC 13G
- Filer
- Dare Bioscience, Inc.
- CIK
- CIK 1401914
- Filed
- Apr 18, 2014
- Reporting period
- Apr 10, 2014
- Description
- Schedule 13G beneficial ownership